14th Nov 2005 07:01
Bespak PLC14 November 2005 For immediate release 14 November 2005 Bespak plc Appointment of Dr. Peter Fellner as Non-Executive Director Bespak plc (LSE: BPK), a leader in specialty medical devices, today announcesthe appointment of Dr. Peter Fellner as a Non-Executive Director with immediateeffect. Dr. Fellner, aged 61, is Chairman of Vernalis plc and Astex Therapeutics Ltd.He is a Non-Executive Director of UCB SA, Qinetiq Group plc, Evotec AG and IsisInnovation Ltd. From 1990 to 2003 he was Chief Executive of Celltech Group plc,following which he was Chairman until 2004, when the business was acquired byUCB. Commenting on Dr. Fellner's appointment, John Robinson, Bespak Chairman,commented: "We are delighted to have attracted an executive of Peter Fellner'sstature to our board. His perspectives on growing technology-led companiesorganically and by acquisition will be invaluable." For further information, please contact: Bespak plc Tel: +44 (0) 1908 525241Mark Throdahl - Chief ExecutiveMartin Hopcroft - Group Finance Director Buchanan Communications Tel: +44 (0) 20 7466 5000Tim Thompson / Mark Court / Mary-Jane Johnson About Bespak plc Bespak, a leader in specialty medical devices, is at the forefront of developingnew delivery systems for the pharmaceutical industry. The company has a productrange covering metered dose inhalers, dry powder device, actuators andcompliance aids. The company also develops and manufactures drug deliverydevices for leading global pharmaceutical companies. The group, which hasfacilities in King's Lynn and Milton Keynes in the UK, is a public companyquoted on the Official List of the London Stock Exhange (LSE: BPK). For moreinformation, please visit www.bespak.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CSRT.L